Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers - Wikidata - wikimedia - TriplyDB

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

http://www.wikidata.org/entity/Q26866157

about

Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer.Trismus following different treatment modalities for head and neck cancer: a systematic review of subjective measures Function preservation using transoral laser surgery for T2-T3 glottic cancer: oncologic, vocal, and swallowing outcomes.Treatment considerations for early glottic carcinoma: lessons learned and a primer for the general otolaryngologist.Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management.DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer Management of radiation wounds.What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review.Management of premalignant lesions of the larynx.Oropharyngeal dysphagia: manifestations and diagnosis.Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.Swallowing performance and tube feeding status in patients treated with parotid-sparing intensity-modulated radiotherapy for head and neck cancer.The lived experience of dysphagia following non-surgical treatment for head and neck cancer.Two-year results of a prospective preventive swallowing rehabilitation trial in patients treated with chemoradiation for advanced head and neck cancer.Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises.An oral cavity squamous cell carcinoma quantitative histomorphometric-based image classifier of nuclear morphology can risk stratify patients for disease-specific survival.Utility of the transnasal esophagoscope in the management of chemoradiation-induced esophageal stenosis.Carers' experiences of dysphagia in people treated for head and neck cancer: a qualitative study.The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer.Individualized outcome prognostication for patients with laryngeal cancer.Treatment of late sequelae after radiotherapy for head and neck cancer.Randomized controlled trial of a multisite speech pathology telepractice service providing swallowing and communication intervention to patients with head and neck cancer: Evaluation of service outcomes.Application of the International Classification of Functioning, Disability and Health (ICF) to people with dysphagia following non-surgical head and neck cancer management.Transoral videolaryngoscopic surgery for oropharyngeal, hypopharyngeal, and supraglottic cancer.

P2860

Q30373904-6B06F9F0-B289-4272-92FB-1DEFD082A504 Q33667302-6D5284C0-D796-4F49-9908-60C2F00BF37A Q33837008-6761BFA4-2F30-4B2E-83EA-85856FC0DA07 Q33840762-EC30961B-67D4-4BB5-914B-CBAF3349D01F Q34659955-B639508E-3DD3-4252-955B-A1A3A6507654 Q35033607-1C01363E-9248-4088-A48D-5FA878917725 Q35751664-61E3E294-A920-4B98-AEBA-886CD987975E Q36156806-93728E11-520C-4789-989B-9A205CD15A68 Q36391099-89258038-252A-49E7-9027-26D7FEAC59CF Q36828409-0E856335-701D-4368-9731-CB810621B27F Q38119441-341784DA-EAF7-4AAD-AACD-D3E483C577B3 Q38139993-ABFD301D-3407-4DBC-9D28-F7F9B8F2DEA2 Q38656025-0FE8FC57-3F04-4BF2-9116-C94DE14F0E77 Q38835143-000BE822-6D3A-4451-85AF-E0C7058B9D0F Q39578584-244B9128-A4C7-47AE-94C0-193983E2E84A Q40323117-270F7A54-1730-4836-A334-91DDDDCF616D Q43620228-2938FDDC-E5C3-4547-A192-2C81D63864F9 Q44004162-11470451-277F-42D0-8F7A-378CFDB28EAC Q45831360-843CF85D-D167-420F-98CF-C64003EFE4E3 Q45946406-B1EB7FCB-9744-4FB0-A89C-EBBE384208C4 Q46396857-A0AA0BA8-FCA2-4E68-A1F7-DDCD3ABE1F7B Q48075935-B1865237-CBFA-450A-A1C6-B1BB21F4CB42 Q48345629-77DFE4B7-0521-41FD-AA1E-3DB618184BB2 Q48350346-4571F407-2577-4A60-84DE-106AD336B21F Q50307416-6F118591-7BC6-48AA-8551-FD4B3295E841 Q52903169-97FFA0A1-502E-47A1-BDD7-7C1B2E35DD14 Q53085927-E8648510-729A-44E1-9C9E-FE159964E596 Q54530709-DB49D59D-F9C3-4D6A-846F-3DA902BC91C3

P2860

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

http://www.wikidata.org/entity/Q26866157

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@ast

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@en

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@nl

type

label

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@ast

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@en

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@nl

prefLabel

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@ast

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@en

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@nl

P1433

Q26866157-450CA589-AD8B-4EE9-A89D-1168101727B8

P1476

Q26866157-EA702A8F-9445-4B4A-82AD-7E0D5E714DCD

P2093

Q26866157-8C4CF1D7-78F8-487B-9CCF-5BE7152B344F

Q26866157-E30A093B-D56E-4A2E-899F-5285408B7E85

P2860

Q26866157-04786676-D35A-4D7D-BE82-14F5617935B6

Q26866157-051502E3-06C5-4C29-ADF6-96F87DAA97C0

Q26866157-0B7FCD53-F598-4C28-9C26-C133C70841EF

Q26866157-0D51210F-3815-4FF7-8FFE-454427097E2A

Q26866157-0E485540-2DD4-4BA8-8CE0-5189378E8BC1

Q26866157-29073373-CF00-4CAC-9AC8-DCA61CDBB438

Q26866157-32B2EA39-3967-48A5-9D66-69D105FF6D5B

Q26866157-32E16D4B-CBCF-4496-9713-D103B1D70B77

Q26866157-3BDE3C86-0294-4DED-B981-738684C9F776

Q26866157-428E6E6B-833D-4853-84BC-5457B8A58612

P2888

Q26866157-6784B447-1204-4D14-AF16-E995375A2241

P304

Q26866157-9D638E43-CF70-4A20-B2C9-82883D0B9FCC

P31

Q26866157-63C20F9F-D543-4FF4-BFDB-09EF111D8C2F

P3181

Q26866157-3FCDBED9-D2D3-45BD-8360-C329BCC0E481

P356

Q26866157-49E932D4-C40A-4005-BFAA-B78088BBD02D

P407

Q26866157-13CC1754-1E81-4DB0-AA1F-8C72F5921654

P433

Q26866157-D3595EA1-843A-4138-A741-300842C3A010

P478

Q26866157-B18E65ED-5A22-4F96-8365-AC57BA36E851

P577

Q26866157-6333F698-43BF-4FB7-978E-45B8A9C2594E

P6179

Q26866157-526925A7-2855-4EC0-8057-BC11AC938D05

P698

Q26866157-3D56DF1B-1875-4BBB-9763-584121F5C819

P921

Q26866157-4F9970FA-7F10-48ED-8E67-FC6D41189800

Q26866157-92B4DBB0-8C4D-4DB0-805C-F1DA25EE741A

P932

Q26866157-94498B1D-4147-4B64-9C9F-92EBC71625A0

P3181

P356

S11912-012-0216-1

P1433

Current Oncology Reports

P1476

Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers

@en

P2093

Jan S. Lewin

http://www.w3.org/2001/XMLSchema#string

Katherine A. Hutcheson

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

The National Cancer Data Base report on squamous cell carcinoma of the base of tongue.

Voice-related quality of life after treatment of laryngeal cancer.

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy

TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?

Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.

Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck.

Dysphagia following chemoradiation for locally advanced head and neck cancer.

P2888

s11912-012-0216-1

P304

158-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3109087

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11912-012-0216-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046457878

http://www.w3.org/2001/XMLSchema#string

P698

22249533

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4012757

http://www.w3.org/2001/XMLSchema#string